Correction: HDAC inhibitors enhance neratinib activity and when combined enhance the actions of an anti-PD-1 immunomodulatory antibody in vivo

Eitemau Tebyg

• HDAC inhibitors enhance neratinib activity and when combined enhance the actions of an anti-PD-1 immunomodulatory antibody in vivo
  gan: Booth, Laurence, et al.
  Cyhoeddwyd: (2017)
• Palbociclib augments Neratinib killing of tumor cells that is further enhanced by HDAC inhibition
  gan: Booth, Laurence, et al.
  Cyhoeddwyd: (2018)
• The Lethality of [Pazopanib + HDAC Inhibitors] Is Enhanced by Neratinib
  gan: Booth, Laurence, et al.
  Cyhoeddwyd: (2019)
• The irreversible ERBB1/2/4 inhibitor neratinib interacts with the BCL-2 inhibitor venetoclax to kill mammary cancer cells
  gan: Booth, Laurence, et al.
  Cyhoeddwyd: (2018)
• [Neratinib + Valproate] exposure permanently reduces ERBB1 and RAS expression in 4T1 mammary tumors and enhances M1 macrophage infiltration
  gan: Booth, Laurence, et al.
  Cyhoeddwyd: (2017)